Why is Hims & Hers Health stock up 3.1% today?

Traders Union
All News
Stocks
Hims & hers health rises 3.19% today

Highlights

Law firms have issued alerts to shareholders of Hims & Hers Health about ongoing class action lawsuits targeting the company.
Current and former investors who experienced significant losses are being urged to contact the legal firms about their rights.
Shares of Hims & Hers Health are showing strong bullish momentum and trade near session highs, but mixed indicator signals and a projected $28.57 to $31.28 range suggest uncertainty over the next five sessions.

Shareholder action alerts spur renewed risk focus among current and former holders

Several law firms have issued alerts to shareholders of Hims & Hers Health regarding ongoing class action lawsuits. Robbins LLP and Bronstein, Gewirtz, and Grossman, LLC are urging investors who have experienced significant losses to contact their firms about their rights in these cases. These notices are directed at both current and former holders of the company.

Anton Kharitonov, expert at Traders Union, notes that the stock’s bullish momentum is overshadowed by ongoing legal risks reflected in active shareholder class actions. He sees divergence among oscillators and weak trend strength as signals to exercise caution, despite the climb across all major moving averages. The negative MACD and neutral ADX highlight the lack of a convincing trend, while overbought pressures and uncertain sentiment create asymmetric risk. Kharitonov is also wary of the overhang from law firm warnings, which could weigh on sentiment and restrict upside potential. "Legal uncertainty remains a major headwind here — I would avoid any aggressive positioning until clarity improves and technical signals align with clear direction," he concludes.

Viktoras Karapetjanc, expert at Traders Union, believes the bullish structure for Hims & Hers Health remains intact. He sees the stock holding above all major moving averages and notes that recent upward momentum confirms resilient demand. The technical backdrop provides opportunity for further growth, with buyers dominating intraday and clear support zones. He argues that despite legal news, the positive trend signals strength and market resilience. "I expect the consolidation phase to create attractive setups — continued buying activity could push HIMS toward a fresh high above $31.28 in the near term," he says.

Sholanke Dele, market strategist, sees legal headlines driving defensive sentiment among investors. The analyst highlights that law firm alerts are undermining confidence and fueling downside probabilities in the short term. Dele is skeptical about the sustainability of recent price gains given the 79% probability of a downward move. "Further volatility is likely as legal risks remain unresolved — caution is essential around HIMS at these levels," Dele warns.

Oscillator divergence tempers strength near resistance as buyers dominate

Hims & Hers Health is trading above its 20-day, 50-day, and 200-day moving averages ($28.59, $29.29, and $27.54 respectively), reflecting strong bullish momentum across short-, medium-, and long-term timeframes. The Ichimoku Kijun sits at $29.4, providing nearby support, with $31.02 as the near-term ceiling and $29.81 (today's high) as the immediate floor. Momentum signals are mixed: the Moving Average Convergence Divergence (MACD) is at -0.01 and forecasts a strong sell, while the Average Directional Index (ADX) indicates a neutral trend with a weak reading of 8.54. The Relative Strength Index (RSI) is at 49.46 and points to a sell, and the Stochastic RSI and Awesome Oscillator both show neutral dynamics. The Commodity Channel Index (CCI) is at 72.95 with a buy signal. Bull/Bear Power (BBP) is positive at 1.59, confirming buyers are dominating intraday, yet its overbought forecast suggests caution. The stock is trading at $29.92, up $0.93 or 3.19%, having opened with a downside gap of -$0.08 (about -0.28%), and is currently near the intraday high with volatility amplitude at 3.15%. This pattern signals strength toward session highs, but the divergence among oscillators indicates an uncertain short-term tone.

Earlier, analysts noted that Hims & Hers Health exhibited bearish technical pressure amid persistent legal uncertainties and heightened volatility risk. The latest data shows this dynamic evolving into a more neutral short-term setup, with attention now focused on the $29.81 support level as a trigger for renewed downside risk if breached.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.